Caidya

Caidya is a global full-service clinical Contract Research Organization (CRO) with offices in 22 locations across the Americas, Europe, and the Asia-Pacific region, employing over 1,700 staff, including more than 700 employees in China. In this unprecedented era of biopharmaceutical innovation and rapid structural changes in global drug development, Caidya is committed to providing one-stop, next-generation clinical CRO services, emphasizing personalized service and innovative solutions. dMed-Clinipace is a leading mid-sized CRO in the global oncology and rare disease fields, with professional expertise in clinical development, regulatory affairs, pharmacovigilance, and clinical data and statistical analysis. It also holds specialized advantages in therapeutic areas such as gastroenterology, nephrology, and women's health. Caidya was formed through the merger of dMed Global, a full-service clinical CRO headquartered in Shanghai, China, and Clinipace, a full-service clinical CRO based in Morrisville, North Carolina, USA.